The decrease or absence sexual desire and arousal is the alteration of the sexual sphere that women most commonly refer to in adulthood and old age. Many women can refer a decrease or absence of desire and / or arousal without having the disorder typified in the DSM-5, but that can cause discomfort, worry and relationship problems in their day to day. Libicare® is a food supplement whose ingredients could have positive effects on the improvement of sexual function in women with low desire and arousal levels. The main ingredients of Libicare® are:

• Trigonella Foenum-graecum (Trigonella) (1)
• Tribulus Terrestris (Tribulus) (2)
• Turnera Diffusa (Damiana) (3)

The main objective is to describe the effectivity of LIBICARE® in the improvement of desire and sexual arousal in women between 45 and 65 years old, in real life.

The secondary objectives of the study are:

• Evaluation of the 6 domains of the EVAS-M scale at 2 and 4 months of treatment.
• Assessment of the safety of LIBICARE® by collecting serious and non-serious adverse events.
• Evaluation of patient satisfaction with treatment at 2 and 4 months of treatment.
• Therapeutic compliance in taking the food supplement at 2 and 4 months of treatment.
• Study of the hormonal variation in relation to the values of total testosterone, free testosterone and SHBG, at the beginning, at 2 months and at 4 months of treatment, in those patients in which it is determined by routine clinical practice.
• To evaluate the degree of usefulness of the EVAS-M scale in clinical practice after 4 months of treatment.

Inclusion Criteria:

• Women between 45 and 65 years old, both ages included.
• Women who refer decreased desire and / or sexual arousal.
• Women who will receive LIBICARE® by prescription of their doctor regardless of their participation or not in the study.
• Women who have given their informed consent in writing.

Exclusion Criteria:

• Women who suffer or have suffered breast cancer.
• Women in anticoagulant treatment.
• Women who, in the opinion of the researcher, cannot follow the study procedures.
• Women not be able to understand the nature of the study, the procedures to follow or who are not authorized to sign an informed consent
• Pregnant or lactating women
• Women with allergies to any of the components of Libicare®

The study population will be women between 45 and 65 years old, both ages included, who present a decrease in sexual desire or arousal